COMPARISON OF PRIMARY ORCHIECTOMY AND POLYESTRADIOL PHOSPHATE IN THE TREATMENT OF ADVANCED PROSTATIC-CANCER

被引:13
作者
HAAPIAINEN, R
RANNIKKO, S
ALFTHAN, O
机构
[1] Second Department of Surgery, Urological Unit, Helsinki University Central Hospital, Helsinki
来源
BRITISH JOURNAL OF UROLOGY | 1990年 / 66卷 / 01期
关键词
D O I
10.1111/j.1464-410X.1990.tb14872.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Summary— The primary clinical efficacy of orchiectomy and polyoestradiol phosphate (PEP) 160 mg/month i.m. was evaluated by progression and cancer mortality rates in a Finnish multicentre study comprising 200 prostatic cancer patients. After the minimum follow‐up time of 2 years there was a significant difference between the groups–orchiectomy delayed progression of the disease more effectively. The follow‐up time is rather short for prostatic cancer, but on the basis of this preliminary study the dose of PEP seems to be insufficient in the treatment of advanced prostatic cancer. © 1990 British Journal of Urology
引用
收藏
页码:94 / 97
页数:4
相关论文
共 9 条
  • [1] HIGH-DOSE POLYESTRADIOL PHOSPHATE WITH AND WITHOUT ACETOSALICYLIC ACID VERSUS ORCHIECTOMY IN THE TREATMENT OF PROSTATIC-CANCER
    ARO, JLV
    HAAPIANINEN, RK
    RANNIKKO, SAS
    ALFTHAN, OS
    [J]. BRITISH JOURNAL OF UROLOGY, 1989, 63 (05): : 512 - 514
  • [2] COMPARISON OF PRIMARY ORCHIECTOMY WITH ESTROGEN THERAPY IN ADVANCED PROSTATIC-CANCER - A 2-YEAR FOLLOW-UP REPORT OF A NATIONAL, PROSPECTIVE PROSTATIC-CANCER STUDY
    HAAPIAINEN, R
    RANNIKKO, S
    ALFTHAN, O
    [J]. BRITISH JOURNAL OF UROLOGY, 1986, 58 (05): : 528 - 533
  • [3] Huggins C, 1941, CANCER RES, V1, P293
  • [4] JONSSON G, 1971, Scandinavian Journal of Urology and Nephrology, V5, P97, DOI 10.3109/00365597109133585
  • [5] NORLEN BJ, 1987, EUR UROL, V13, P193
  • [6] SCHROEDER FH, 1984, PROSTATE, V5, P181
  • [7] HORMONAL-THERAPY OF PROSTATIC-CANCER
    SCOTT, WW
    MENON, M
    WALSH, PC
    [J]. CANCER, 1980, 45 (07) : 1929 - 1936
  • [8] SINGLE DRUG POLYESTRADIOL PHOSPHATE (PEP) THERAPY IN PROSTATIC-CANCER (CAP)
    STEGE, R
    CARLSTROM, K
    COLLSTE, L
    ERIKSSON, A
    HENRIKSSON, P
    [J]. EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1987, 23 (08): : 1249 - 1249
  • [9] STEROID-SENSITIVE PROTEINS, GROWTH-HORMONE AND SOMATOMEDIN-C IN PROSTATIC-CANCER - EFFECTS OF PARENTERAL AND ORAL ESTROGEN THERAPY
    STEGE, R
    FROHLANDER, N
    CARLSTROM, K
    POUSETTE, A
    VONSCHOULTZ, B
    [J]. PROSTATE, 1987, 10 (04) : 333 - 338